Target Name: OR10A5
NCBI ID: G144124
Review Report on OR10A5 Target / Biomarker Content of Review Report on OR10A5 Target / Biomarker
OR10A5
Other Name(s): Olfactory receptor 10A5 | Olfactory receptor, family 10, subfamily A, member 1 | JCG6 | Olfactory receptor-like protein JCG6 | Olfactory receptor, family 10, subfamily A, member 5 | olfactory receptor 10A1 | Olfactory receptor OR11-85 | Olfactory receptor family 10 subfamily A member 5 | Olfactory receptor 11-403 | olfactory receptor-like protein JCG6 | Olfactory receptor 10A1 | OR10A1 | O10A5_HUMAN | olfactory receptor OR11-85 | HP3 | OR11-403 | olfactory receptor, family 10, subfamily A, member 1 | olfactory receptor family 10 subfamily A member 5 | olfactory receptor 11-403

Potential Drug Target and Biomarker for Various Diseases: OR10A5

Olfactory receptor 10A5 (OR10A5) is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR10A5 has been identified as a potential drug target and a biomarker for various diseases, including cancer, depression, and neurological disorders.

OR10A5 is a transmembrane protein that is composed of an extracellular portion and an intracellular portion. The extracellular portion of OR10A5 consists of a N-terminus that is involved in cell adhesion and a C-terminus that is involved in protein-protein interactions. The intracellular portion of OR10A5 contains a catalytic domain and a cytoplasmic tail that is involved in the regulation of intracellular signaling pathways.

OR10A5 is involved in the sense of smell and is responsible for the detection of various scents, including sweet, sour, and umami. OR10A5 is also involved in the regulation of the production of olfactory neurons, which are responsible for transmitting the sense of smell to the brain.

OR10A5 has been identified as a potential drug target due to its involvement in various diseases. One of the main reasons for its potential as a drug target is its involvement in cancer. OR10A5 has been shown to be involved in the regulation of cell proliferation and has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer.

OR10A5 has also been shown to be involved in the regulation of depression. Studies have shown that OR10A5 is involved in the regulation of neurotransmitter synthesis and release, which is a key aspect of the regulation of mood. Additionally, OR10A5 has been shown to be involved in the regulation of inflammatory responses, which is another key aspect of the regulation of mood.

OR10A5 has also been shown to be involved in the regulation of neurological disorders. Studies have shown that OR10A5 is involved in the regulation of neurotransmitter synthesis and release, which is a key aspect of the regulation of movement and muscle tone. Additionally, OR10A5 has been shown to be involved in the regulation of pain perception, which is a key aspect of the regulation of neurotransmitter synthesis and release.

In conclusion, OR10A5 is a protein that is involved in the sense of smell and has been shown to be involved in the regulation of various diseases, including cancer, depression, and neurological disorders. As a result, OR10A5 is a potential drug target and a biomarker for these diseases. Further research is needed to fully understand the role of OR10A5 in disease and to develop effective treatments.

Protein Name: Olfactory Receptor Family 10 Subfamily A Member 5

Functions: Odorant receptor (Potential). May be involved in taste perception

The "OR10A5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10A5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2